Trans-NIH Research Opportunities in Pediatrics

Loading... Loading video...

Air date:	Friday, September 12, 2008, 10:00:00 AM Time displayed is Eastern Time, Washington DC Local
Views:	Total views: 91 * This only includes stats from October 2011 and forward.
Category:	Special
Runtime:	00:59:01
Closed captioning:	Check box to display CC outside of the video Note: You can drag the captioning window around and resize it
Description:	OPASI ROUNDS Lecture Series Dr. Alexander will discuss a number of new and emerging opportunities for pediatric research existing at NIH and offering the potential for collaborative research for many Institutes. They originate from new or revised legislation as well as from Roadmap initiatives. This presentation will focus on a number of these opportunities, including the National Children’s Study, Newborn Screening, Best Pharmaceuticals for Children, Pediatric Medical Devices, the Biomarkers Consortium and Clinical and Translational Science Awards. The Office of Portfolio Analysis and Strategic Initiatives (OPASI) provides the National Institutes of Health (NIH) and its constituent Institutes and Centers (ICs) with the methods and information necessary to manage their large and complex scientific portfolios, identifies – in concert with multiple other inputs – important areas of emerging scientific opportunities or rising public health challenges, and assists in the acceleration of investments in these areas, focusing on those involving multiple ICs.

NLM Title:	Trans-NIH research opportunities in pediatrics / Duane Alexander.
Author:	Alexander, Duane F. National Institutes of Health (U.S.)
Publisher:
Abstract:	(CIT): OPASI ROUNDS Lecture Series. Dr. Alexander will discuss a number of new and emerging opportunities for pediatric research existing at NIH and offering the potential for collaborative research for many Institutes. They originate from new or revised legislation as well as from Roadmap initiatives. This presentation will focus on a number of these opportunities, including the National Children"s Study, Newborn Screening, Best Pharmaceuticals for Children, Pediatric Medical Devices, the Biomarkers Consortium and Clinical and Translational Science Awards. The Office of Portfolio Analysis and Strategic Initiatives (OPASI) provides the National Institutes of Health (NIH) and its constituent Institutes and Centers (ICs) with the methods and information necessary to manage their large and complex scientific portfolios, identifies - in concert with multiple other inputs - important areas of emerging scientific opportunities or rising public health challenges, and assists in the acceleration of investments in these areas, focusing on those involving multiple ICs.
Subjects:	Biomedical Research Environmental Exposure Health Surveys Interinstitutional Relations Pediatrics
Publication Types:	Webcast
NLM Classification:	WS 20
NLM ID:	101486627
CIT Live ID:	6757
Permanent link:	https://videocast.nih.gov/watch=6757

NIH VideoCasting